News & Articles

The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company's diagnostic portfolio

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

New assay is designed to help laboratories address greater demand for opioid testing

The Atellica Solution from Siemens Healthineers promises more control and increased simplicity in your lab workflows

The Siemens Healthineers High-Sensitivity Troponin I assays can detect lower levels of troponin compared to conventional assays

World-renowned laboratories’ workflow and performance studies succeeded in KPIs such as turnaround time, throughput, hands-on system time, and assay performance

Discover the Scientists' Choice Award nominee Atellica Solution at AACC July 29 - August 2, 2018

Siemens becomes a preferred supplier for automation solutions

Testing at the point-of-care improves patient care with results in less than a minute

FTD's broad range of CE-marked infectious disease detection tests and syndromic panels expands the Siemens Healthineers molecular diagnostics portfolio

Proven nephelometric technology provides high precision, reproducibility, and antigen-excess security for confident clinical decisions

Revolutionary new chemistry analyzers said to offer flexibility, simplified workflow and tighter control gain CE Mark

The new MR scanner provides an enhanced level of detail for musculoskeletal and neurological applications, giving clinicians improved diagnostic capabilities

Fast, accurate and actionable test results allow clinicians to confidently rule in/rule out a myocardial infarction when triaging patients with chest pain

Automated repeat and confirmatory testing of reactive samples through SMART algorithm software and Hot Zone capabilities reduce the need for additional testing

New test provides improved accuracy in identification of HCV genotype and subtype for guiding selection of optimal therapeutic treatment for individuals with Hepatitis C

Facility will manufacture assays for the next-generation laboratory system, the Atellica Solution*